Jeremy Roach
6Patents
1h-index
23Co-inventors
43Inventor score
Filing activity: Dec 19, 2019 → Feb 9, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11459329B2 | Imidazopyridazine and imidazopyridine compounds and uses thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US12012409B2 | Bicyclic heterocycles as FGFR inhibitors | Chemistry; Metallurgy | 1 | Active |
| US12378243B2 | Quinoline compounds as inhibitors of KRAS | Human Necessities | 0 | Active |
| US12030889B2 | Imidazopyridazine and imidazopyridine compounds and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11427592B2 | Imidazopyridazine and imidazopyridine compounds and uses thereof | General | 0 | Revoked |
| US11566028B2 | Bicyclic heterocycles as FGFR inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.